Inventor · disambiguated record
William Vernier
Also filed as: VERNIER WILLIAM · VERNIER WILLIAM F · VERNIER WILLIAM FRANCOIS
46 granted patents·20 pending applications·619 citations·filing 2000–2025
99Inventor score
Top patents by PatentIndex Score
66 records- 0198US6723752B2(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Apr 20, 2004·53 cites·31 claims
- 0298US6458803B1Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Oct 1, 2002·48 cites·13 claims
- 0397US6476075B1Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Nov 5, 2002·29 cites·13 claims
- 0496US6723753B2Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Apr 20, 2004·22 cites·34 claims
- 0596US6710089B2Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Mar 23, 2004·23 cites·16 claims
- 0695US6683099B2Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 27, 2004·19 cites·16 claims
- 0795US6462092B1Use of substituted N, N-disubstituted reverse aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Oct 8, 2002·23 cites·13 claims
- 0895US6451823B1Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Sep 17, 2002·18 cites·13 claims
- 0994US6677375B2Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·19 cites·18 claims
- 1094US6455519B1Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Sep 24, 2002·17 cites·14 claims
- 1194US6451830B1Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Sep 17, 2002·17 cites·13 claims
- 1294US6448295B1Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Sep 10, 2002·17 cites·12 claims
- 1393US6765023B2Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPFIZER·Filed 2002·Granted Jul 20, 2004·14 cites·18 claims
- 1493US6521607B1(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Feb 18, 2003·17 cites·31 claims
- 1593US6479552B2Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Nov 12, 2002·15 cites·13 claims
- 1692US6803388B2(R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPFIZER·Filed 2001·Granted Oct 12, 2004·15 cites·29 claims
- 1792US6677379B2Substituted N,N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·12 cites·18 claims
- 1892US6677353B2Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·12 cites·18 claims
- 1992US6586433B2Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Jul 1, 2003·13 cites·31 claims
- 2092US6476057B1Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Nov 5, 2002·12 cites·12 claims
- 2192US6458849B1use of substituted N,N-disubstituted mercapto amino compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Oct 1, 2002·12 cites·13 claims
- 2291US6696472B2Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Feb 24, 2004·11 cites·18 claims
- 2391US6677341B2(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Jan 13, 2004·13 cites·40 claims
- 2491US6544974B2(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Apr 8, 2003·13 cites·14 claims
- 2591US6458852B1Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activitySEARLE & CO·Filed 2001·Granted Oct 1, 2002·10 cites·13 claims
- 2690US6677380B2Substituted N, N-disubstituted mercapto amino compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·11 cites·18 claims
- 2790US6583183B2Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Jun 24, 2003·11 cites·25 claims
- 2889US6683113B2(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2001·Granted Jan 27, 2004·11 cites·31 claims
- 2988US9932345B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Apr 3, 2018·3 cites·35 claims
- 3088US6750228B1Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2000·Granted Jun 15, 2004·35 cites·44 claims
- 3188US6699898B2Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP GLOBAL PATENT D·Filed 2002·Granted Mar 2, 2004·11 cites·18 claims
- 3287US6696435B2Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Feb 24, 2004·7 cites·20 claims
- 3386US6683093B2Aromatic sulfone hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2001·Granted Jan 27, 2004·27 cites·93 claims
- 3485US2025092047A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 3584US10981916B2Substituted pyrazolopyrimidinone compounds as PDE2 inhibitorsDART NEUROSCIENCE LLC·Filed 2017·Granted Apr 20, 2021·2 cites·20 claims
- 3680US6677382B1Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2002·Granted Jan 13, 2004·10 cites·18 claims
- 3779US7119203B2Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitorsPHARMACIA CORP·Filed 2003·Granted Oct 10, 2006·11 cites·2 claims
- 3878US11186582B2Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 3977US2025136604A1Substituted pyrazolopyrimidinone compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 4077US2023192698A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 4174US2007219274A1(R)-Chiral Halogenated Substituted Fused Heterocyclic Amino Compounds Useful for Inhibiting Cholesterol Ester Transfer Protein ActivityPFIZER·Filed 2007·Application pending·0 cites
- 4273US6750233B2Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2001·Granted Jun 15, 2004·6 cites·103 claims
- 4372US11999738B2Substituted pyrazolopyrimidinone compounds as PDE2 inhibitorsDART NEUROSCIENCE LLC·Filed 2021·Granted Jun 4, 2024·0 cites·22 claims
- 4468US7700658B2(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activityPFIZER·Filed 2008·Granted Apr 20, 2010·0 cites·4 claims
- 4568US2024391930A1Spirocyclic bicyclic modulators of cholesterol biosynthesis and their use for promoting remyelinationGENENTECH INC·Filed 2024·Application pending·0 cites
- 4667US2024400579A1Spirocyclic modulators of cholesterol biosynthesis and their use for promoting remyelinationGENENTECH INC·Filed 2024·Application pending·0 cites
- 4767US2024398781A1Spirocyclic cyclic modulators of cholesterol biosynthesis and their use for promoting remyelinationGENENTECH INC·Filed 2024·Application pending·0 cites
- 4863US7253211B2(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activityPFIZER·Filed 2006·Granted Aug 7, 2007·0 cites·4 claims
- 4963US2005137220A1Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 5061US10501465B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William Vernier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →